Salute e Benessere

K18 STRENGTHENS COMMITMENT TO UK PRO COMMUNITY WITH ANNOUNCEMENT OF NEW…

Sweet Squared joins as a new distributor for K18, serving professional salons across England and Wales. Sweet Squared joins as a new distributor for K18, serving professional salons acrossEnglandandWales. Capital Hair & Beauty, a longstanding K18 partner, will continue its role as a wholesale distributor forEngland,Wales, and nowScotland.Scotlandwill continue to also be serviced by K18 Distributor Warehouse5. We're proud to join hands with Sweet squared and Capital...
PR Newswire
02/07/2025

SurgiBox Expands European Presence Through Strategic Partnership with Ondatec…

Ondatec is a well-established Turkish company operating in the field of medical devices, hospital equipment, and healthcare technologies. The company proudly contributes to the development of the healthcare sector by providing innovative, reliable, and high-quality products to both public and private hospitals throughout Türkiye. With strong expertise in marketing and sales, Ondatec is positioned as a reliable partner in the industry.The partnership will enable SurgiBox to leverage...
Nasdaq GlobeNewswire
02/07/2025

Invitation: Sobi's Q2 report

The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com before the conference call. The presentation can be followed livehere or afterwards on sobi.com. The slides will be made available onsobi.com before the conference call. To participate in the conference call, please use the following dial-in details: Sweden : +46 8 5051 0031 United Kingdom : +44 207 107 06 13 United States : +1 631 570 56 13 For other...
PR Newswire
02/07/2025

Croatia Poliklinika: Croatia Transforms Bus Stops into Waiting Rooms and Digital…

"In Croatia, nearly half the population unknowingly faces potential spine issues. Reluctance to seek professional help has led to what is commonly known as a silent pandemic, hurting the nation's collective spine with alarming numbers. But now, we made sure the innovation steps in where the hesitation prevails. ," said Dr. Tatjana Kujundžić, head of Croatia Polyclinics. "InCroatia, nearly half the population unknowingly faces potential spine issues. Reluctance to seek professional…
PR Newswire
02/07/2025

Safe Life acquires Salvavidas Cardio, enters Spanish AED market

Salvavidas is led by a strong management team, and under this team has shifted its business model and exhibited considerable growth over the past few years. With strong focus on customer experience, they have built an efficient structure and operation which enables delivery of goods and services across all of Spain, and they are poised to continue this growth path. Salvavidas is led by a strong management team, and under this team has shifted its business model and exhibited considerable…
PR Newswire
02/07/2025

OSE Immunotherapeutics met à jour l’information sur les procédures en cours

OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)announces that following the hearing on June 24th, 2025, the President of the Nantes Commercial Court rejected, pursuant to an order dated July 1, 2025, the motions brought by the group of shareholders acting in concert, seeking the retraction of the order of June 10, 2025, authorizing the adjournment of the OSE’s annual...
Nasdaq GlobeNewswire
02/07/2025

New ECCIA-Bain report: Europe's high-end sector sounds alarm on tariffs, skills…

BRUSSELS, July 2, 2025 /PRNewswire/ -- Latest figures released by the European Cultural and Creative Industries Alliance (ECCIA) show that Europe's high-end and luxury sector represents 5% of Europe's GDP. The sector continues to drive economic growth, preserve cultural heritage, and champion excellence well beyond the continent. The new report, developed with the technical collaboration of Bain & Company for ECCIA, also indicates that the sector's global leader status with 70% global market…
PR Newswire
02/07/2025

Granting of Stock Options and Vesting of Restricted Share Units

In accordance with the Remuneration Policy of Alvotech (the “Company”), which was approved at the Company’s Annual General Meeting (“AGM”) on June 6, 2023, at the 2025 AGM held on June 25, 2025, four independent board directors each received a stock option grant allowing the purchase of up to 24,784 Alvotech shares.The aim of the stock option grants is to align the long-term interests of the board members and the Company. The relevant key terms and conditions of the Company´s Equity...
Nasdaq GlobeNewswire
02/07/2025

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth…

Key Takeaways from the NADPH Oxidase (NOX)-Replacement Therapies Market Report Key Takeaways from the NADPH Oxidase (NOX)-Replacement Therapies Market Report Discover which indication is expected to grab the major NADPH oxidase (NOX)-replacement therapies market share @ NADPH Oxidase (NOX)-Replacement Therapies Market Report NADPH Oxidase (NOX)-Replacement Therapies Market Dynamics The NADPH oxidase (NOX) replacement therapies market is gradually gaining traction asscientific...
PR Newswire
01/07/2025

Frontotemporal Dementia Market Sees Rise in Precision Medicine and Gene Therapy…

Key Takeaways from the Frontotemporal Dementia Market Report Key Takeaways from the Frontotemporal Dementia Market Report Discover frontotemporal dementia new treatment @ New Treatments for Frontotemporal Dementia Frontotemporal Dementia Market Dynamics The frontotemporal dementia market dynamics are expected to change in the coming years. Emerging drugs are poised for market leadership due to theabsence of an approved treatmentfor FTD, asrising case numbersdrive urgent...
PR Newswire
01/07/2025

Novo Holdings portfolio company Kate Farms acquired by Danone

Kate Farms to expand further as it becomes part of Danone's North America Medical Nutrition business Kate Farms to expand further as it becomes part of Danone's North America Medical Nutrition business SAN FRANCISCO , July 1, 2025 /PRNewswire/ -- Novo Holdings, a leading life science investor, today announced that its portfolio company Kate Farms has been acquired by Danone, a global leader in food and nutrition. The acquisition represents a significant milestone for Kate Farms, a...
PR Newswire
01/07/2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2025

Aggregatedpresentationbydayandbymarket Statement of transactions in own shares from June 23rd to June 27th 2025 Name of the issuerIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1123/06/2025FR0010259150 ...
Nasdaq GlobeNewswire
01/07/2025

Eurobio Scientific completes the acquisition of Life Science unit of Voden…

Eurobio Scientific completes the acquisition of Life Science unitof Voden Medical Instruments Spa in ItalyParis, July 1st, 2025 Eurobio Scientific(FR0013240934, ALERS), (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro specialty medical diagnostics and life sciences, today announces the completion of the acquisition of the assets of the Life Science unit of Voden Medical Instruments Spa 1. The unit focuses on diagnostics, cellular and molecular biology...
Nasdaq GlobeNewswire
01/07/2025

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics

In addition to tracking individual cases, STAgora™ enables users to monitor outbreaks across selected regions, both local and international. This capability provides real-time visibility into disease spread, enhancing situational awareness and supporting timely, data-driven public health responses. By equipping national and global health authorities with real-time epidemiological insight, the platform is expected to strengthen decision-making and support the development of effective response…
PR Newswire
01/07/2025

Field Medical Closes Oversubscribed $35 Million Series B to Advance Development…

"Ventricular tachycardia is among the most underpenetrated segments in electrophysiology, yet physicians still lack the tools they need," said Steven Mickelsen, MD, founder and CEO of Field Medical. "What is exciting is how VT is mirroring the early days of the AF market, strong clinical demand unmet by existing technology. We are poised to unlock this opportunity with our next-generation therapy built for speed, precision and real clinical progress, advancing toward pivotal…
PR Newswire
01/07/2025

Residual DNA Testing to Hit $370M by 2030 -- The Silent Guardian of Biologics…

The global residual DNA testing market, valued at US$0.27 billion in 2024, stood at US$0.28 billion in 2025 and is projected to advance at a resilient CAGR of 6.0% from 2025 to 2030, culminating in a forecasted valuation of US$0.37 billion by the end of the period. Behind this steady surge lies a critical mission—ensuring biologics are safe, compliant, and globally trusted. With biosimilar and biologic approvals accelerating, and regulatory oversight tightening across FDA, EMA, and ICH, residual…
PR Newswire
01/07/2025

Biosimilars Market Size to Hit $76.2 Billion by 2030 - Driving Value-Based Care…

The Global Biosimilars Market size is projected to be valued at USD 27.20 billion in 2023 and reach USD 76.20 billion by 2030, growing at a CAGR of 15.9% according to a new report by The Research Insights. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options. The report runs an in-depth…
PR Newswire
01/07/2025

Metabolon's Untargeted Metabolomics Services Used for Breakthrough Study…

Globally, approximately 537 million adults have diabetes, predominantly type 2, with numbers expected to rise significantly by 2045. Major risk factors include obesity, physical inactivity, and advancing age. Type 2 diabetes notably increases the risk of severe complications such as cardiovascular disease, kidney disease, diabetic retinopathy, and neuropathy. Globally, approximately 537 million adults have diabetes, predominantly type 2, with numbers expected to rise significantly by 2045...
PR Newswire
01/07/2025

Sandoz further asserts leadership in biosimilars, breaking ground on new…

MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of USD 222 billion over next 10 yearsOngoing investment in in-house manufacturing to create end-to-end leading European biosimilar hub, capital expenditure commitments remain unchangedMost recent USD 440 million investment in new production plant in Brnik, due to open in 2028, brings total planned investment in Slovenia to more than USD 1...
Nasdaq GlobeNewswire
01/07/2025

Evaxion announces changes to Executive Management to optimize the value of…

Chief Executive Officer (CEO) Christian Kanstrup steps down Chief Scientific Officer Birgitte Rønø appointed interim CEO and search for new CEO has commencedThomas Schmidt appointed permanent Chief Financial Officer COPENHAGEN, Denmark, July 1, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces several key executive management changes to optimize value from its proprietary...
Nasdaq GlobeNewswire
01/07/2025

WHO and Its Chinese and European Partners Jointly Launch Multilateral…

A key milestone was the official launch of the Geneva 1.5°C Proactive Health Initiative, marking the world's first transnational academic-industry-government platform focused on climate-health governance in urban contexts. A key milestone was the official launch of the Geneva1.5°C Proactive Health Initiative ,marking the world's first transnational academic-industry-government platform focused on climate-health governance in urban contexts. The roundtable focused on three core...
PR Newswire
01/07/2025

Q'Apel Medical Appoints Stewart Strong as President and Chief Executive Officer

"Stew is the right person at the right time to lead Q'Apel through our next phase of growth," remarked R. King Nelson, Q'Apel's Chairman of the Board. "He brings a passion for building and leading high-performing global teams and for developing commercial strategies to drive sustainable growth, which will serve him well as Q'Apel looks to accelerate our commercial performance in the U.S. and ramp up our global presence." "Stew is the right person at the right time to…
PR Newswire
01/07/2025

Rob Pupelis of AAI & Spectros Named Twice in the 2025 Business Worldwide…

With increasing consumer interest in non-invasive procedures and preventative care, medical aesthetics is no longer considered niche. Instead, it is being embraced as a key part of long-term wellness, with an estimated market value of $20 billion in the US alone by 2026. AAI & Spectros sits at the forefront of this shift, offering a portfolio of technologies that cater to both aesthetic and reconstructive clinical settings. Under Pupelis' guidance, the company has positioned itself as a…
PR Newswire
01/07/2025

EnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology Assets

"This strategic acquisition accelerates our mission to visualize and treat AF with unprecedented efficiency and precision," said Jun Feng, CEO of EnChannel Medical. "By building on prior advancements and leveraging our proprietary technologies, we are shaping the future of persistent AF diagnosis and treatment." "This strategic acquisition accelerates our mission to visualize and treat AF with unprecedented efficiency and precision," said Jun Feng , CEO of EnChannel…
PR Newswire
01/07/2025
Altri  Comunicati